Specialised nutrition and health divisions have helped to balance global food giants Nestlé and Danone after each reported a slowdown in sales across core areas of business as the impact of acquisitions, divestment's and ‘currency headwinds’ took...
Strong first-quarter growth for pharmaceutical and speciality ingredients player Lonza will pave the way for higher-than-expected sales growth in 2017, said the firm as it upgraded its full-year outlook.
Danish bioscience firm Chr. Hansen is raising its revenue predictions by 11-13 per cent for 2010/11 after what it describes as “strong growth” in its first quarter from the September 1, 2010 to the end of November.
Naturex is ready to implement the next step in its plan to make
more strategic acquisitions in the food and nutraceuticals sector
plan after raising €13.2m by issuing more than a quarter of a
million new shares.